Compare AII & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AII | CYRX |
|---|---|---|
| Founded | 2006 | 1999 |
| Country | United States | United States |
| Employees | 313 | 1100 |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 357.1M | 419.3M |
| IPO Year | N/A | 2008 |
| Metric | AII | CYRX |
|---|---|---|
| Price | $19.44 | $10.66 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 8 |
| Target Price | ★ $26.33 | $13.31 |
| AVG Volume (30 Days) | 85.4K | ★ 393.6K |
| Earning Date | 06-08-2026 | 05-06-2026 |
| Dividend Yield | ★ 5.20% | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | N/A | ★ 1.40 |
| Revenue | N/A | ★ $176,177,000.00 |
| Revenue This Year | $35.92 | $11.06 |
| Revenue Next Year | $17.74 | $8.45 |
| P/E Ratio | ★ $4.12 | $7.39 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $15.78 | $5.31 |
| 52 Week High | $26.36 | $11.45 |
| Indicator | AII | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 53.41 | 77.36 |
| Support Level | $18.63 | $9.18 |
| Resistance Level | $19.51 | $11.33 |
| Average True Range (ATR) | 0.55 | 0.41 |
| MACD | 0.06 | 0.18 |
| Stochastic Oscillator | 71.57 | 99.23 |
American Integrity Insurance Group Inc is engaged in the property and casualty insurance business. It provides personal residential property insurance for single-family homeowners and condominium owners as well as coverage for vacant dwellings and investment properties, predominantly in Florida. The Company's property and casualty insurance is currently offered in Florida, North Carolina, South Carolina, and Georgia.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.